fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Divis Laboratories Ltd

Divis Laboratories Ltd

Updated on March 19, 2019

Stock/Share Code - DIVISLAB

Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its Custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Below is the details of DIVISLAB Divis Laboratories Ltd

Market Cap₹43,915 Cr.
Current Price ₹1,705.75 as on 25 Mar 19
52 Week High / Low Price₹1,697.65 / ₹981.05
Face Value₹2
Stock P/E33.65
Book Value₹237.46
Dividend Yield0.60 %
ROCE21.37 %
ROE15.34 %
Sales Growth (3yrs)7.36 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 26.54%
Cons:

Divis Laboratories Ltd Price Chart

Divis Laboratories Ltd Price Chart

Divis Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹373.9 33.65 ₹43,915.14 Cr. 0.60 ₹379.49 Cr. 68.92 29.39 1342.92 21.37
2. Lupin ₹729.05 36.30 ₹34,556 Cr. 0.65 -₹151.75 Cr. -125.86 13.31 4504.87 10.21
3. Jubilant Life ₹722.75 15.06 ₹12,481.15 Cr. 0.38 ₹260.84 Cr. 22.73 14.96 2377.10 15.26
4. Vinati Organics ₹1,584.8 29.47 ₹7,422.66 Cr. 0.31 ₹70.68 Cr. 122.75 63.24 303.05 27.52
5. Granules India ₹110.55 12.88 ₹2,484 Cr. 1.02 ₹60.32 Cr. 72.24 53.82 631.78 11.92
6. Suven Life Scie. ₹260.55 21.20 ₹3,065.6 Cr. 0.62 ₹25.23 Cr. -27.08 -21.17 129.02 25.09
7. Shilpa Medicare ₹353.45 27.70 ₹2,855.07 Cr. 0.20 ₹12.47 Cr. -8.73 -6.52 173.43 10.12

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Divis Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
Sales1,1031,0171,0059761,0678218901,0381,0889951,2851,343
YOY Sales Growth %35.04%25.77%4.26%13.58%-3.33%-19.27%-11.46%6.29%1.99%21.2%44.35%29.39%
Expenses704613714599705576613712701643771820
Material Cost %42.7%37.87%38.27%35.91%39.47%40.38%40.14%39.35%37.47%38.32%36.83%35.76%
Employee Cost %8.94%9.44%17.87%10.59%9.95%12.26%11.77%11.08%11.56%12.19%10.48%10.16%
Operating Profit399404291378362245277326386352514523
OPM %36%40%29%39%34%30%31%31%36%35%40%39%
Other Income171620222130341748498035
Interest20001010-0103
Depreciation293031313132343739424242
Profit before tax385390280368350242276306396358552513
Tax %16%23%20%27%26%27%25%26%34%26%28%26%
Net Profit322302224268259177207225262266398379
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales7251,0331,1919291,3151,8452,1292,5143,0843,7204,0243,8164,711
Sales Growth %90.16%42.43%15.28%-21.98%41.49%40.31%15.39%18.09%22.67%20.63%8.17%-5.17%%
Expenses4796167015178091,1491,3061,4921,9142,3142,5832,5612,935
Material Cost %44.68%39.85%37.29%31.85%40.35%41.92%37.47%36.52%39.41%40.17%39.12%40.4%%
Manufacturing Cost %6.36%6.47%6.81%7.99%7.2%6.99%9.49%9.18%8.93%8.47%7.64%9.19%%
Employee Cost %4.19%4.16%4.91%7.16%8.52%7.87%8.98%8.97%9.18%9.49%12.19%11.69%%
Other Cost %10.86%9.17%9.83%8.68%5.49%5.52%5.43%4.67%4.54%4.09%5.25%5.83%%
Operating Profit2464174904125056968231,0221,1701,4061,4401,2551,776
OPM %34%40%41%44%38%38%39%41%38%38%36%33%38%
Other Income1414233129664981369274109212
Interest111073253334323
Depreciation2236485153627792136118123142165
Profit before tax2273854583884796957921,0091,0671,3751,3881,2191,819
Tax %15%8%7%11%9%21%23%22%21%19%24%29%
Net Profit1923544243444365466117928471,1111,0538701,305
EPS in Rs7.3613.5216.1312.5315.6219.5121.7528.1329.8741.8439.6832.76
Dividend Payout %7%7%9%23%30%32%33%34%31%24%25%31%

Compounded Sales Growth

  • 10 Years:: 13.96%
  • 5 Years:: 12.38%
  • 3 Years:: 7.36%
  • TTM:: 23.46%

Compounded Profit Growth

  • 10 Years:: 9.45%
  • 5 Years:: 7.36%
  • 3 Years:: 0.76%
  • TTM:: 50.46%

Return on Equity

  • 10 Years:: 24.19%
  • 5 Years:: 22.73%
  • 3 Years:: 20.93%
  • TTM:: 15.34%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital13131326272727272753535353
Equity Capital12.9112.9112.9526.4326.5226.5526.5526.5526.5553.0953.0953.09
Reserves5298611,2491,5161,8022,1482,5273,0083,5354,3045,3565,9076,251
Borrowings154865333235533182742366315
Other Liabilities156237260313460574612731886640807798986
Trade Payables101.49149.73155.66157.56121.24157.31180.04164.47246.74313.9467.81427.15536.23
Total Liabilities8521,1971,5751,8882,3112,8053,1983,7844,4755,0406,2526,8217,304
Fixed Assets3814975905905907389081,2221,3091,4391,5591,9961,996
Gross Block490.66641.92782.49832.65885.341091.631337.881739.791952.42195.421793.572372.92
Accumulated Depreciation109.47145.05192.82242.98295.61353.44429.38518.19643.67756.78234.62377.04
CWIP38632024104182303144218264444120244
Investments1561724425284804115057368131,6391,8971,881
Other Assets4325817938331,0891,4051,5751,9132,2122,5242,6102,8093,183
Inventories210.05275.65395.91479.57543.07650.97805.95893.271114.91162.891255.761281.391501.57
Trade receivables164.46214.24283.5234.44392.78533.97558.9791.64823.03966.121002.891112.111304.12
Cash Equivalents17.2212.6112.8712.8712.821.8234.6835.7756.6659.3866.4791.4891.92
Loans n Advances40.3978.22100.82106.1462.7669.1368.6156.8668.38140.88125.01192.8939.4
Total Assets8521,1971,5751,8882,3112,8053,1983,7844,4755,0406,2526,8217,304

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity1903023013683263344835588221,0361,149765
Profit from operations281.32444.25551.7409.7503.17715.94846.591078.71175.511444.571469.331249.08
Working Capital Changes-64.79-106.8-211.8212.48-143.79-259.15-189.3-307.22-141.64-147.34-18.52-215.81
Taxes paid-26.97-35.34-39.09-54.51-33.42-122.74-174.46-213.33-211.43-260.89-301.7-268.55
Cash from Investing Activity-158-235-217-317-222-204-254-305-521-411-1,137-476
Fixed Assets Purchased-150.16-171.05-110.33-60.17-162.63-289.12-340.03-246.37-307.14-395.71-376.53-273.87
Fixed Assets Sold00.110.030.340.010.0369.220.090.0500.050.13
Investments purchased0-55.57-167.11-314.38-668.32-51.6500-231.13-69.52-1252.06-745
Investments sold0050.8744.91583.86100.350-94.060-2.39424.99489.11
Cash from Financing Activity-34-65-82-48-104-131-231-248-303-6303-314
Proceeds from Shares0.0904.0226.284.511.39000000
Proceeds from Borrowings34.15003.378.0336.58008.75000
Repayment of Borrowings-30.37-67.87-33.44-23.16-17.84-2.36-22.37-14.64-0.5516.3500
Interest Paid-9.15-7.95-4.17-1.28-0.68-2.51-0.77-0.91-0.57-1.65-2.25-1.33
Dividends Paid-25.730-30.27-45.52-92.45-154.17-200.55-232.95-310.59-639.020-319.25
Net Cash Flow-3213-0-1-25-1-515-25

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %40%48%41%27%28%34%33%36%32%35%28%21%
Debtor Days8376879210910696115979591106
Inventory Turnover3.684.253.552.122.573.092.922.963.073.273.333.01

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Divis Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.